Registration for a live webinar on 'The role of T cells in COVID from asymptomatic to severe outcomes' is now open.
See webinar detailsDr. Michael Rafferty University of Kansas, USA
1 TalkBiography
Michael F. Rafferty is adjunct professor of medicinal chemistry at the University of Kansas. He trained at the University of Kansas and the National Institutes of Health before joining Parke-Davis Pharmaceuticals in 1984. His drug discovery research interests are CNS diseases and oncology, and the application of core enabling technologies... read moreto enhance productivity and reduce risks.